Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Portugal Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20152
20161
20173
20215
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Active, not recruiting2
Recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S2
BAR Pharmaceuticals s.r.l.1
Boehringer Ingelheim1
Eli Lilly and Company1
Genfit1
Gilead Sciences1
Intercept Pharmaceuticals1
Inventiva Pharma1
Merck Sharp & Dohme LLC1
Newcastle University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease14
Fibrosis3
Fatty Liver2
Carcinoma, Hepatocellular1
Cardiovascular Diseases1
Diabetes Mellitus, Type 21
Dyslipidemias1
Hypertension1
Liver Cirrhosis1
Liver Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.